Contract facts
UnrestrictedNo full NAICS 621511 intel page yet. Browse NAICS intelligence
Glucose Strips is a federal Unrestricted award for Defense Health Agency Hcd West held by Nova Biomedical Corp. Estimated value $219K ($155K obligated). Current period of performance ends Jan 17, 2026 (potential Jan 17, 2028). Last award drew 1 bidder. Place of performance: CAMP PENDLETON CA. Related solicitation HT941023N0003.
Glucose strips. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Jan 17, 2026 (273 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT941023P0014? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNova Biomedical Corp — $2.5M obligated across 67 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT941023P0014?
HT941023P0014 (Glucose strips) is a Defense Health Agency Hcd West award with a potential value of $219K, currently held by Nova Biomedical Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9410-23-P-0014?
HT9410-23-P-0014 is the dashed form of PIID HT941023P0014 (Glucose strips), held by Nova Biomedical Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT941023P0014?
Defense Health Agency Hcd West awarded HT941023P0014 to Nova Biomedical Corp (potential $219K).
Who is the incumbent on HT941023P0014?
Nova Biomedical Corp is the incumbent with $2.5M across 67 related awards in SCOUT’s public footprint. The current period of performance ends Jan 17, 2026.
When does Nova Biomedical Corp’s HT941023P0014 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 17, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT941023P0014? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.